Prostaglandin E2 as a mediator of fever:: The role of prostaglandin (EP) receptors

被引:58
|
作者
Oka, T [1 ]
机构
[1] Univ Occupat & Environm Hlth, Dept Neurol, Div Psychosomat Med, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan
来源
关键词
prostaglandin E-2; EP receptors; fever; psychological stress-induced hyperthermia; review;
D O I
10.2741/1458
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Prostaglandin E-2 (PGE(2)) is a principal fever mediator that induces hyperthermia when injected into the organum vasculosum lamina terminalis (OVLT) and the adjacent preoptic area of the hypothalamus (POA). PGE (EP) receptors have four subtypes, i.e. EP1, EP2, EP3, and EP4. In the rat OVLT/POA region, at least three of these receptors, i.e. EP1, EP3, and EP4 receptors, have distinctively different distribution patterns. In rats, intracerebroventricular injection of EP1 receptor agonists and EP3 receptor agonists increased core temperature (Tc) and that of an EP4 receptor agonist decreased it. IntraPOA injection of an EP1 receptor agonist increased Tc. IntraPOA injection of an EP3 receptor agonist, however, induced hyperalgesia but not hyperthermia. Studies using mice with EP receptor gene deletions have indicated that EP3 receptors play a crucial role in febrile response. Therefore, the involvement of EP3 receptors at other levels of the nervous system should be considered. Such nuclei include the raphe pallidus nucleus, intermediolateral cell column in the spinal cord, or the nucleus of the solitary tract.
引用
收藏
页码:3046 / 3057
页数:12
相关论文
共 50 条
  • [21] Biphasic actions of prostaglandin E2 on the renal afferent arteriole -: Role of EP3 and EP4 receptors
    Tang, LL
    Loutzenhiser, K
    Loutzenhiser, R
    CIRCULATION RESEARCH, 2000, 86 (06) : 663 - 670
  • [22] An Inflammatory Mediator, Prostaglandin E2, in Colorectal Cancer
    Wang, Dingzhi
    DuBois, Raymond N.
    CANCER JOURNAL, 2013, 19 (06): : 502 - 510
  • [23] Role of EP4 prostaglandin E2 receptor in the ischemic liver
    Kuzumoto, Y
    Sho, M
    Ikeda, N
    Mizuno, T
    Hamada, K
    Akashi, S
    Tsurui, Y
    Kashizuka, H
    Nomi, T
    Kanehiro, H
    Nakajima, Y
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (01) : 422 - 424
  • [24] Identification of specific prostaglandin E2 (EP) receptors that inhibit alloimmune responses.
    Nataraj, C
    Thomas, DW
    Mannon, RB
    Koller, BH
    Coffman, TM
    TRANSPLANTATION, 2000, 69 (08) : S305 - S305
  • [25] Characterization of the Signaling Modalities of Prostaglandin E2 Receptors EP2 and EP4 Reveals Crosstalk and a Role for Microtubules
    Vleeshouwers, Ward
    van den Dries, Koen
    de Keijzer, Sandra
    Joosten, Ben
    Lidke, Diane S.
    Cambi, Alessandra
    FRONTIERS IN IMMUNOLOGY, 2021, 11
  • [26] The role of prostaglandin E2 in endometriosis
    Sacco, Keith
    Portelli, Mark
    Pollacco, Joel
    Schembri-Wismayer, Pierre
    Calleja-Agius, Jean
    GYNECOLOGICAL ENDOCRINOLOGY, 2012, 28 (02) : 134 - 138
  • [27] Prostaglandin E2 receptors in bone formation
    Li, M.
    Thompson, D. D.
    Paralkar, V. M.
    INTERNATIONAL ORTHOPAEDICS, 2007, 31 (06) : 767 - 772
  • [28] Nuclear localization of prostaglandin E2 receptors
    Bhattacharya, M
    Peri, KG
    Almazan, G
    Ribeiro-Da-Silva, A
    Shichi, H
    Durocher, Y
    Abramovitz, M
    Hou, X
    Varma, DR
    Chemtob, S
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) : 15792 - 15797
  • [29] Prostaglandin E2 receptors in bone formation
    M. Li
    D. D. Thompson
    V. M. Paralkar
    International Orthopaedics, 2007, 31 : 767 - 772
  • [30] Microsomal prostaglandin E synthase-1 contributes to ischaemic excitotoxicity through prostaglandin E2 EP3 receptors
    Ikeda-Matsuo, Y.
    Tanji, H.
    Ota, A.
    Hirayama, Y.
    Uematsu, S.
    Akira, S.
    Sasaki, Y.
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 160 (04) : 847 - 859